The Boston Globe
By Scott Allen
The biggest study ever of drugs for schizophrenia should help psychiatrists get away from trial and error in treating their patients with the debilitating mental illness, its authors said yesterday. But the $44 million federally funded research project also reached a much darker conclusion: None of the drugs works very well.
Nearly [...]
